Consumer Staples
Highlights Portfolio Strategy A battle between tighter monetary conditions and the anticipation of fiscal largesse will be a dominant market theme this year. Our high-conviction equity allocation calls do not require making a major directional global economic bet, or second guessing the Fed's desire to continue tightening. The bulk of our calls could currently be considered contrarian, based on recent market momentum and sub-surface relative valuation swings. Recent Changes S&P Insurance Index - Downgrade to high-conviction underweight. Nasdaq Biotech Index - Downgrade to high-conviction underweight. Feature Stocks have already paid for a significant acceleration in earnings and economic growth this year and beyond. Fourth quarter earnings season will be the first real test of investor expectations since the post-election market surge. While recent data have been encouraging, forward corporate profit guidance is unlikely to be robust in the face of the U.S. dollar juggernaut. Currently, the hope is that fiscal stimulus will offset tighter monetary settings, ultimately delivering a higher plane of economic activity. The major risks are that the economy loses momentum before fiscal spending cranks up, and/or that profits diverge from a more resilient economic performance than liquidity conditions forecast. Indeed, fiscal stimulus isn't slated to accelerate until next year (Chart 1), while the impact of anti-growth market moves is far more imminent. Our Reflation Gauge has plunged, heralding economic disappointment (Chart 1). With the economy near full employment, Fed hawkishness could persist even in the face of any initial evidence of economic cooling. Under these conditions, the gap between nominal GDP and 10-year Treasury yields could turn negative in the first half of the year (Chart 2), which would be a major warning sign for stocks. Chart 1Fiscal Stimulus Is Still A Long Way Off Chart 2Warning Signal As a result, while the market has recently been focused almost solely on return, our emphasis at this juncture is on minimizing risk. That is consistent with the historic market performance during Fed tightening cycles. Going back to the early-1970s and using the last seven Fed interest rate hiking periods, it is evident that non-cyclical sector relative performance benefits immensely on both a 12 and 24 month horizon from the onset of Fed tightening (Charts 3 and 4). Cyclical sectors typically lag the broad market, while financials generally market perform1. Chart 312-Month Performance After Fed Hikes Chart 424-Month Performance After Fed Hikes Some of the other major macro forces that are likely to influence the broad market and sectoral trends are: Ongoing strength in the U.S. dollar and its drag on top-line growth: loose fiscal policy and tight monetary policy is a classic recipe for currency strength. Tack on high and rising interest rate differentials due to policy divergences with the rest of the world (Chart 5), and exchange rate strength is likely to persist in the absence of a major domestic economic downturn. A tough-talking Fed. Wage growth is accelerating and broadening out, and will sharpen the Fed's focus on inflation expectations. With dollar strength constraining revenue growth potential, strong wage gains are profit margin sapping (Chart 2). A divergence between economic growth and profit performance, i.e. stronger growth is unlikely to feed into equal growth in corporate sector earnings given the squeeze on profit margins from a recovery in labor's ability to garner a larger share of aggregate income. Disappointment and/or uncertainty as to the timing and rollout of the much anticipated fiscal spending programs and unfunded tax cuts. Favoring domestic vs. global exposure will remain a key theme. Emerging markets (EM) have not validated the sharp jump in the global vs. domestic stocks, nor cyclical vs. defensives (Chart 6). Chart 5Greenback Is A Drag##br## On S&P 500 Top Line Growth Chart 6Mind##br## The Gap EM stocks are pro-cyclical, and outperform when economic growth prospects are perceived to be improving. The surging U.S. dollar is a growth impediment for many developing countries with large foreign liabilities to service. The U.S. PMI is gaining vs. the Chinese and euro area PMI (Chart 7, second panel), heralding a rebound in cyclical share price momentum. World export growth remains anemic and will remain so based on EM currency trends (Chart 7). When compared with the reacceleration in U.S. retail sales, the outlook for domestically-sourced profits is even brighter. The other key sectoral theme is to favor areas geared to the consumer rather than the corporate sector. Consumer income statements and balance sheets are far healthier than those of the corporate sector (Chart 8). As a result, they are in a more propitious position to spend and expand. Chart 7Domestics Will Rise To The Occasion Chart 8Consumers Trump The Corporate Sector We expect all of these forces to truncate rally attempts in 2017. The market is already stretching far enough technically to flag risk of a potentially sizeable correction in the first quarter, i.e. greater than 10%, particularly given the significant tightening in monetary conditions and overheating bullish sentiment that have developed. In other words, it is not an environment to chase the post-election winners, nor turn bearish on the losers that have been eschewed. Against this backdrop, we are introducing our top ten high-conviction calls for 2017. As always, these calls are fundamentally-based and we expect them to have longevity and/or meaningful relative return potential, rather than just reflect recent momentum trends. We recognize the difficulty of trading in and out of positions on a short-term basis. Energy Services - Overweight Chart 9Playable Rally The energy sector scores well in relative performance terms when the Fed is hiking interest rates2, supporting a high-conviction overweight in the energy services group. OPEC's agreement to curtail production should hasten supply/demand rebalancing that was already slated to occur via non-OPEC production declines through 2017. U.S. shale producers slashed capital expenditures by 65% from 2014 to 2016, and the International Oil Companies reduced capital expenditures by 40% over the same period. OPEC's decision to trim output should mitigate downside commodity price risks, providing debt and equity markets with confidence to restore capital availability to the sector. With easier access to capital, producers, especially shale, will be able to accelerate drilling programs in a stable commodity price environment. The three factors traditionally required to sustain a playable rally are now in place. The rig count has troughed. The growth in OECD oil inventories has crested. The latter is consistent with a gradual rise in the number of active drilling rigs. Finally, global oil production growth is falling steadily. Pricing power is likely to be slow to recover this cycle given the scope of previous capacity excesses, but even a move to neutral would remove a major drag and reduce the associated share price risk premium (Chart 9). Consumer Staples - Overweight 2016 delivered a number of company specific body blows to the consumer staples sector, most notably concerns about the pharmacy benefit manger pricing model, which undermined the retail drug store group. Thereafter, the sector was shunned on a macro level following the election, as it was used as a source of capital to fund aggressive purchases in more cyclical sectors. This has set the stage for a contrarian buying opportunity in a high quality, defensive sector with one of the best track records during Fed tightening cycles3. The sector is now closing in on an undervalued extreme, in relative terms, having already reached such a reading in technical terms (Chart 10). Our Cyclical Macro Indicator is climbing, supported by the persistent rise in consumers' preference for saving. The latter heralds an increase in outlays at non-cyclical retailers relative to sales at more discretionary stores. Importantly, consumer staples exports have reaccelerated, despite the strong U.S. dollar, pointing to a further acceleration in sector sales growth, and by extension, free cash flow. The strong U.S. dollar is a major boon, from an historical perspective, given that it typically creates increased global economic and market volatility. The latter is starting to pick up (Chart 10). A strong currency, particularly bilaterally against China, also implies a reduction in the cost of imported goods sold, and heralds a relative performance rebound (Chart 11). Chart 10Contrarian Buy Chart 11China To The Rescue? Home Improvement Retail - Overweight Enticing long-term housing prospects argue for looking through the recent rise in mortgage rates. Household formation is reaccelerating, as full employment is boosting consumer confidence, and clocking at a higher speed than housing starts. The implication is that pent-up housing demand will be unleashed. In fact, consumers have only recently started re-levering, with banks more than willing to facilitate renewed appetite for mortgage debt. Remodeling activity is booming and anecdotes of house flipping activity picking up steam are corroborating that the housing market is vibrant. Now that house prices have recently overtaken the 2006 all-time highs, the incentive to upgrade and remodel should accelerate. While the recent backup in bond yields has been a setback for housing affordability, the U.S. consumer is not priced out of the housing market. Yields are rising in tandem with job security and wages. Mortgage payments remain below the long-term average as a share of income and effective mortgage rates remain near generationally low levels. Building supply store construction growth has plumbed to the lowest level since the history of the data. Historically, capacity restraint has represented a boost to home improvement retail (HIR) profit margins and has been inversely correlated with industry sales growth. Stable housing data and improving operating industry metrics entice us to put the compellingly valued S&P HIR on our high-conviction buy list for 2017 (Chart 12). Chart 12Benefiting From Enticing##br## Long-Term Housing Prospects Chart 13Healthy Consumer Is A Boon##br## To Consumer Finance Stocks Consumer Finance - Overweight We are focusing our early-cyclical exposure on overweighting the still bruised S&P consumer finance index. This group is levered to the rising interest rate environment and debt-financed consumer spending. The selloff in the 10-year Treasury bond has been closely correlated with relative performance gains and the current message is to expect additional firming in the latter (Chart 13, top panel). Importantly, higher interest rates have boosted credit card interest rate spreads (the industry's equivalent net interest margin metric), underscoring that the next leg up in relative share prices will be earnings led (Chart 13, bottom panel). On the consumer front, consumer finances are healthy, the job market is vibrant and consumer income expectations are on the rise. In addition, house prices have vaulted to fresh all-time highs and are still expanding on a y/y basis. The positive wealth effect provides motivation for consumers to run down savings rates (Chart 13, second & third panels). Health Care Equipment - Overweight Health care equipment (HCE) stocks have been de-rated alongside the broad health care index, trading at a mere market multiple and below the historical mean, representing a buy opportunity. Revenue growth has been climbing at a double digit clip (Chart 14, third panel) and the surging industry shipments-to-inventories ratio is signaling that still depressed relative sales growth expectations will surprise to the upside (Chart 14, top panel). Synchronized global growth is also encouraging for U.S. medical equipment exports, despite the U.S. dollar's recent appreciation. The ageing population in the developed markets along with pent up demand for health care services in the emerging markets where a number of countries are developing public safety nets, bode well for HCE long-term demand prospects. The bottom panel of Chart 14 shows that the global PMI has been an excellent leading indicator of HCE exports and the current message is positive. The recent contraction in valuation multiples suggests that sales are expected to disappoint in the coming year, an outlook that appears overly cautious, especially within the context of the nascent improvement in industry return on equity (Chart 14, second panel). Chart 14HCE Stocks Are Cheap Given##br## Improving Final Demand Outlook Chart 15More Than##br## Meets The Eye REITs - Overweight REITs have traded as if the back up in global bond yields will persist indefinitely, and that the level of interest rates is the only factor that drives relative performance. Improving cash flows and cheap valuations suggest that REITs can decouple from bond yields. Our REIT Demand Indicator (RDI) has climbed into positive territory, signaling higher rental inflation. The latter is already outpacing overall CPI by a wide margin. The RDI is also positively correlated with commercial property prices, implying more new highs ahead. That will support higher net asset values. While increased supply is a potential sore spot, particularly in the residential space, multifamily housing starts have rolled over relative to the total, suggesting that new apartment builds are diminishing. As discussed in previous research reports, contrary to popular perception, relative performance is also depressed from a structural perspective. REIT relative performance is trading well below its long-term trend, a starting point which has historically overwhelmed any negative pressure from a Fed tightening cycle (Chart 15). Tech Hardware Storage & Peripherals - Underweight The S&P technology hardware storage & peripherals (THSP) sector is a disinflationary play (10-year treasury yield change shown inverted, second panel, Chart 16) and benefits when prices are deflating, not when there are whiffs of inflation4. The tech sector has the highest foreign sales/EPS exposure among the top 11 sectors, and the persistent rise in the greenback is weighing on export prospects for the THSP sub-index (Chart 16, third panel), and by extension top and bottom line growth. Computer and electronic products new order growth has fallen sharply recently, warning that THSP sales growth will remain downbeat. Industry investment is also probing multi-year lows (not shown). Asian inventory destocking is ongoing, which will pressure selling prices, but the end of this liquidation phase would be a signal that the worst will soon be over. Technical conditions are bearish. A pennant formation signals that a breakdown looms. Chart 16Tech Stocks Hate Reflation Chart 17Shy Away, Don't Be Brave Biotech - Underweight The Nasdaq biotech index is following the BCA Mania Index, which includes previous burst bubbles in a broad array of asset classes. The top panel of Chart 17 shows that if history at least rhymes, biotech bubble deflation is slated to continue. Only 45 stocks in the NASDAQ biotech index have positive 12-month forward earnings estimates, comprising 27% of the 164 companies in the index according to Bloomberg. There is still a lot of air to be taken out of the biotech bubble. Historically, interest rates and relative performance have been inversely correlated. The back up in bond yields and Fed tightening represent a draining in liquidity conditions which bodes ill for higher beta and more speculative investments. The biotech derating has been earnings driven and a sustained multiple compression period looms, especially given the sector's poor sales prospects (Chart 17, bottom panel) Worrisomely, not only have biotech stocks fallen despite Trump's win, but recent speculative zeal (buoyant equity sentiment and resurging margin debt, not shown) has also failed to reinvigorate biotech equities. The NASDAQ biotech index is a sell (ETF ticker: IBB:US). Industrials - Underweight The industrials sector was added to our high-conviction underweight list late last year so the turn in calendar does not require a change in outlook. The sector has discounted massive domestic fiscal stimulus and disregarded the competitive drag on earnings from the U.S. dollar, trading as if a profit boom is imminent. Recent traction in surveys of industrial activity is a plus, but is more a reflection of an improvement in corporate sentiment and is unlikely to translate into imminent industrials sector profit improvement. The U.S. dollar surge is a direct threat to any benefit from an increase in domestic infrastructure or private sector investment spending. Commodity prices and EM drag when the dollar is strong. Chronic surplus EM industrial capacity remains a source of deflationary pressure for their currencies, economies and U.S. industrial companies. U.S. dollar strength warns of renewed pricing power pressure (Chart 18). Non-tech industrial capacity is growing faster than output, and capital goods imports prices are contracting (Chart 18). Tack on the relentless surge in the U.S. dollar, and a new deflationary wave appears inevitable. Relative forward earnings momentum is already negative, and is likely to remain so given the barriers to a top-line recovery, and a soaring domestic wage bill. The sector is not priced for lackluster earnings. Chart 18Fade The Bounce Chart 19Advance Is Precarious Insurance - Underweight Insurance stocks have benefited from the upward shift in the yield curve and the re-pricing of the overall financials sector, but the advance is precarious. Previously robust insurance pricing power has cracked. The CPI for household insurance is barely growing. The latter is typically correlated with auto premiums, underscoring that they may also slip (Chart 19). While higher interest rates are positive for investment portfolio income, they also imply mark-to-market losses on bond portfolios and incent insurers to underwrite at a faster pace with more lenient standards, which is often a precursor to increased competition and less pricing power. Insurance companies have added massively to cost structures in recent years (Chart 19), while the rest of the financials sector was shedding labor costs. Relative valuations have enjoyed a step-function upshift, but the path of least resistance will be lower for as long as relative consumer spending on insurance products retreats on the back of pricing pressure (Chart 19). 2016 Review... Last year's high-conviction calls were hot out of the gate, and generally had very strong gains until the late-summer/early-fall, but were hijacked by the post-election surge in a few sectors. As a result of the end of year fireworks, our high conviction calls trailed the market by just under 2% for the year ending 2016. Had we had the foresight to predict a Trump win and a massive market rally, we could have closed our positions in early November for comfortably positive gains. In total, our average booked gains in the year were 3% in excess of the broad market since the positions were initiated. We are also closing our pair trades, and will re-introduce a number of new trades in the near future. Anastasios Avgeriou, Vice President Global Alpha Sector Strategy & U.S. Equity Strategy anastasios@bcaresearch.com 1 Please see the U.S. Equity Strategy Special Report titled: "Sector Performance And Fed Tightening Cycles: An Historical Roadmap", available at uses.bcaresearch.com. 2 Ibid 3 Ibid 4 Please see the U.S. Equity Strategy Special Report titled: "Equity Sector Winners And Losers When Inflation Climbs", available at uses.bcaresearch.com. Current Recommendations Current Trades Size And Style Views Favor small over large caps. Favor growth over value (downgrade alert).
The sudden economic exuberance following the Trump election victory has caused a flight out of traditional safe havens that looks to have gone too far. For instance, consumer products stocks (household products, beverages and packaged food) are now trading below the broad market P/E multiple, in aggregate, on a trailing 12-month basis. The chart shows that forward relative returns have typically been very robust when the group trades at a discount to the market. What could go wrong? History shows that a period of stable and strong GDP growth can cause discounted valuations to persist. Pricing in such an outlook at this juncture is overly optimistic, given the unknown fallout from a strong U.S. dollar on the rest of the world, trade uncertainty, and potential financial strains in the heavily indebted corporate sector as a consequence of rising bond yields. Keep in mind that the consumer products has a positive correlation with the U.S. dollar (top panel). We would be buyers on recent share price weakness.
Highlights Portfolio Strategy Retail food stocks are deep into the buy zone. Deflating food costs augur well for profit margins in the coming quarters. Lift the financial sector to neutral, via the asset manager and investment bank indexes. Recent Changes S&P Financials Sector - Raise to neutral, recording a loss of 8%. S&P Asset Manager & Custody Bank Index - Raise to overweight from underweight, locking in a profit of 5%. S&P Investment Bank & Brokerage Index - Raise to neutral, recording a loss of 3%. Table 1Sector Performance Returns (%) Equity markets celebrated the surprise Republican U.S. election victory. Investors believe the regime shift will entail fiscal stimulus and a lifting in regulatory constraints that stir animal spirits and lift the economy out of its growth funk. The reality is that it is premature to make long-term assumptions. Meanwhile, the underlying fragility of the U.S. economic expansion will be tested in the coming quarters. Indeed, it is easy to envision a hit to business confidence, causing delays in decision making and investment, especially given Trump's anti-trade rhetoric and penchant for profligacy. Policy uncertainty and confidence have been reliable leading indicators for valuations, and slippage would put upward pressure on the Equity Risk Premium (Chart 1). It will be critical to monitor aggregate financial conditions. The Goldman Sachs Financial Conditions index has tentatively edged up (Chart 1), and if corporate bond spreads, long-term yields and the U.S. dollar move much higher, upside risks will intensify. The low level of overall potential growth has made the economy increasingly sensitive to swings in financial conditions and deflationary impulses from abroad. Both the high yield and investment-grade corporate bond index are languishing, perhaps picking up on the deflationary signal from U.S. dollar strength and growth drag from higher Treasury yields (Chart 2, bottom panel). It is notable that emerging markets currencies have pulled back. These exchange rates are typically pro-cyclical. Sustained currency weakness typically leads to domestic corporate bond spread widening (Chart 2, CDX spreads shown inverted). In the past five years, it has paid to bet on defensive over cyclical sectors when EM currencies weaken and CDX spreads are this tight, i.e. contrarians should take note. At a minimum, it may be a signal that global growth is less robust than the rise in global bond yields implies. As a result, forecasts for double-digit profit growth in the next twelve months look very aggressive, even if our economic outlook proves too cautious. The tentative trough in third quarter S&P 500 profits has not yet been validated by other indicators. For example, tracking tax revenue provides a good real-time gauge on corporate sector cash flows. Federal income tax receipts have dropped into negative territory. Corporate income taxes are contracting. Previous major and sustainable overall profit recoveries have been either led by, or coincident with, corporate income tax growth (Chart 3). This argues against extrapolating positive third quarter earnings growth in the S&P 500. Chart 1Watch Confidence And Financial Conditions Chart 2Don't Get Caught Up In The Hype Chart 3Taxes And Profits Rather than get overly excited about the potential for a new fiscal spending impulse, it may be more appropriate to view the latter as truncating downside economic risks, given that the corporate sector remains a key headwind to stronger growth, even excluding its balance sheet stress. Consequently, we still expect undervalued defensives to retake a leadership role from overvalued cyclical sectors and we also retain a domestic vs. global bias. If the U.S. dollar breaks above its recent trading range, the odds of the broad market making further liquidity fueled gains will diminish significantly. Importantly, the last few days of market moves have been massively exaggerated, as industrials and materials have rallied as if fiscal stimulus is about to hit next month. Even when implemented, it is not a panacea for sector earnings. Drug and biotech stocks have soared as if pricing pressures will evaporate, when in reality price pressures emerged prior to any political interference. Tech stocks have been crushed because of fears they will be forced to move production back to the U.S. All of these knee-jerk reactions should be treated with caution, with the exception of financials, where a step function reduction in the risk premium may be underway. There Is A New Sheriff In Town: Lift Financials To Neutral Financials have celebrated the modest upshift in the interest rate structure and hopes for a reversal of the regulatory framework that has been a structural noose on profitability, and risk premiums. These factors, along with our domestic vs. global bias, argue against maintaining a below benchmark weighting on a tactical basis. As discussed last week, our view on banks remains cautious, however, asset managers and investment banks have lower odds of falling back toward recent lows even after election euphoria inevitably fades. The largest earnings drags from the past year have eased. M&A activity has troughed. New and secondary stock offerings have hooked back up and margin debt is back to new highs, suggesting that investor risk appetites have stopped shrinking (Chart 4). Thus, capital formation is unlikely to dry up, even if upside is limited given poor corporate sector balance sheet health and an upward creep in the cost of capital. In terms of asset managers and custody banks (AMCB), even modestly higher interest rates would reduce a major profit impediment. Fees on funds held in trust have been decimated by ZIRP, underscoring that the latest uptick in short-term Treasury yields is a plus. Relative performance had already diverged negatively from the stock-to-bond ratio, the equity risk premium and global economic sentiment (Chart 5). This gap could close with a prospective thawing in relations between lawmakers and the industry. There is still structural downward pressure on fees as low cost ETFs gain market share, but that is being partially offset by the renewed growth in total mutual fund assets (Chart 4, bottom panel). Bear in mind that both groups tend to do well when the stocks outperform bonds, as seems likely in the near run given creeping protectionism. In sum, despite our concerns about overall financial sector productivity growth, mainly owing to rising bank cost structures, and the risks of a renewed deflationary impulse from U.S. dollar strength, we are lifting sector weightings to neutral. This will put us onside with the objective message from our Cyclical Macro Indicator, the buy signal from our Technical Indicator (Chart 6) and our broader theme of favoring domestic vs. global industries. Chart 4Earnings Drivers Have Stabilized Chart 5Recovery Candidate Chart 6Following Our Indicators Bottom Line: The Republican victory has provided a fillip to the financials sector, and underweight positions putting underweight positions offside. We are lifting allocations to neutral, via the S&P AMCB and S&P investment banks & brokerage indexes. AMCB moves to overweight, and the latter to neutral, with an eye to downgrading again once euphoria fades and investor focus returns to economic durability. Food Retailers: Too Cheap To Overlook Food retailers offer attractive value, defensive and domestic equity exposure with the potential for upside profit surprises. This group will benefit if U.S. wage inflation persists. The latter would boost consumer purchasing power and could lead to tighter financial conditions, either through U.S. dollar strength and/or a tighter Fed. The defensive appeal of retail food equities would shine through under that scenario. The starting point for grocery stocks is extremely appealing. The price ratio is extraordinarily oversold. It fell farther below its 200-day moving average than at any time since 2002, before recently bouncing (Chart 7). Valuations are cheap, return on equity is solid and share prices have diverged negatively from a number of macro indicators. For instance, relative performance has been tightly linked with the U.S. dollar, but the former plunged even as the currency firmed (Chart 8, top panel). A strong exchange rate will keep a lid on imported food costs, boost the allure of domestically-oriented industries while lifting consumer spending power. Chart 7Extraordinarily Oversold Chart 8Top-Line Improvement Ahead Outlays on food products have climbed as a share of total spending in the past six months, reversing a long-term downtrend (Chart 8). If consumer confidence stays firm as a consequence of rising wage growth and a positive wealth effect, then it is conceivable that store traffic and total grocery spending will accelerate. The surge in capital spending in recent years reflects store upgrades and a refreshed shopping experience, which could also translate into faster sales growth. Now that capital spending growth is cooling, it will reduce a profit margin drag. Profitability should also benefit from cost deflation. The food manufacturing PPI is contracting, reflecting shrinking raw food prices (Chart 9, top panel, shown inverted). It is normal for food stocks to outperform when raw food prices fall. Importantly, capacity utilization rates in the packaged food industry are very low (Chart 9), which augurs well for ongoing pricing pressure among suppliers. Tack on deflation in industry wage inflation, and it is no wonder profit margins have been able to grind back toward previous highs without a strong sales impulse. If sales rebound, as seems likely given evidence of market share gains away from hypermarkets (Chart 10, bottom panel), then grocery stores should continue to demonstrate decent pricing power gains (Chart 10, middle panel). Chart 9Cost Deflation Chart 10Gaining Market Share Adding it up, the ingredients for a powerful rally in the S&P retail food store index exist, with good downside protection should the economy disappoint on the back of tighter financial conditions. Bottom Line: We recommend an overweight position in the S&P retail food store index (BLBG: S5FDRE - KR, WFM). Current Recommendations Current Trades Size And Style Views Favor small over large caps and growth over value.
Consumer product stocks have had a tough few weeks, as renewed strength in the U.S. dollar threatens to undermine sales prospects. However, there are reasons to be cautiously optimistic, especially in relative terms. Consumption has a lower economic beta than capital spending, particularly among consumer staples vendors. Consumer goods exports have started to rebound, even prior to renewed strength in emerging market currencies. The latter heralds at least a mild recovery in consumer product top-line growth. Domestically, retail sales at non-discretionary stores are outpacing sales at discretionary stores by a wide margin, another indication that in relative terms, profit conditions favor non-cyclical consumer goods vendors. We are overweight the S&P household products and S&P soft drink indexes.
Consumer products stocks are likely to move to an even larger valuation premium before the cyclical outperformance phase ends.
Drug retail relative valuations have divorced from bullish indicators of top and bottom-line performance. Retail sales momentum continues to accelerate. The ongoing hospital hiring frenzy is indicative of rising procedures, and provides a good indication for future prescription drug demand, and thus pharmacy retail sales. Importantly, drug retailers are gaining market share from hypermarkets (third panel), underscoring that they will receive a disproportionate share of rising store traffic. From a contrarian perspective, there appears to be little buy in to a positive sales view, given that analysts have pared back relative sales growth expectations (fourth panel). Meanwhile, investors have attached a massive risk premium to the group (bottom panel). There is room for both profit and multiple expansion, and we reiterate a high-conviction overweight. The ticker symbols for the stocks in this index are: BLBG: S5DRUG - CVS, WBA.
The S&P retail drug store index has been undermined by concerns about the opaque pricing structure of its pharmacy benefits management arms, which has pushed relative valuations to extremely attractive levels. While it is difficult to forecast whether any major concessions will be made to appease health insurers, this focus is masking an increasingly upbeat picture for the rest of the core business. Consumers are allocating a record share of their spending to pharmacy-related items, continuing a trend in place for more than two decades. It is rare for relative performance to deviate from relative spending trends for long, as the latter provides a clear indication of the industry's ability to deliver better-than-market profitability. Importantly, drug retailers have retrenched in recent years, paving the way for solid same-store sales growth. Shorter-term performance indicators are even more upbeat, please see the next Insight. The ticker symbols for the stocks in this index are: BLBG: S5DRUG - CVS, WBA.